Joshua L.D. Parris

798 total citations
9 papers, 552 citations indexed

About

Joshua L.D. Parris is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Joshua L.D. Parris has authored 9 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Joshua L.D. Parris's work include Immunotherapy and Immune Responses (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Joshua L.D. Parris is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Joshua L.D. Parris collaborates with scholars based in United States, Germany and Slovakia. Joshua L.D. Parris's co-authors include Maureen E. Murphy, Nathaniel W. Snyder, Alessandro Carrer, Sophie Trefely, Kathryn E. Wellen, Thibaut Barnoud, Marco Trizzino, Sydney L. Campbell, Ben Z. Stanger and Simone Sidoli and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Cancer Discovery.

In The Last Decade

Joshua L.D. Parris

9 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua L.D. Parris United States 6 359 252 143 76 68 9 552
Subreen A. Khatib United States 12 335 0.9× 265 1.1× 243 1.7× 101 1.3× 52 0.8× 18 648
Bincy Philip United States 2 254 0.7× 223 0.9× 169 1.2× 30 0.4× 52 0.8× 2 455
Mark Schreuder Netherlands 7 236 0.7× 273 1.1× 96 0.7× 35 0.5× 82 1.2× 10 488
Ryoichi Asaka Japan 15 297 0.8× 158 0.6× 88 0.6× 45 0.6× 38 0.6× 38 634
Shuijie Li China 13 248 0.7× 139 0.6× 96 0.7× 40 0.5× 29 0.4× 31 466
Mengxue Yu China 14 258 0.7× 128 0.5× 113 0.8× 103 1.4× 20 0.3× 28 511
Kristofor A. Olson United States 7 313 0.9× 244 1.0× 55 0.4× 45 0.6× 58 0.9× 12 466
Adviti Naik Qatar 13 276 0.8× 127 0.5× 206 1.4× 36 0.5× 43 0.6× 22 547
Gillian Moore Ireland 9 178 0.5× 90 0.4× 130 0.9× 45 0.6× 31 0.5× 16 414
Wen‐Lian Chen China 10 262 0.7× 186 0.7× 74 0.5× 50 0.7× 20 0.3× 20 419

Countries citing papers authored by Joshua L.D. Parris

Since Specialization
Citations

This map shows the geographic impact of Joshua L.D. Parris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua L.D. Parris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua L.D. Parris more than expected).

Fields of papers citing papers by Joshua L.D. Parris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua L.D. Parris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua L.D. Parris. The network helps show where Joshua L.D. Parris may publish in the future.

Co-authorship network of co-authors of Joshua L.D. Parris

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua L.D. Parris. A scholar is included among the top collaborators of Joshua L.D. Parris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua L.D. Parris. Joshua L.D. Parris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Parris, Joshua L.D., Gauri Mirji, Thibaut Barnoud, et al.. (2023). The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition. Cancer Research Communications. 3(7). 1200–1211. 3 indexed citations
2.
Parris, Joshua L.D., Thibaut Barnoud, Julia I-Ju Leu, et al.. (2021). HSP70 Inhibition Blocks Adaptive Resistance and Synergizes with MEK Inhibition for the Treatment of NRAS-Mutant Melanoma. Cancer Research Communications. 1(1). 17–29. 4 indexed citations
3.
Yarmarkovich, Mark, Alvin Farrel, Moreno Di Marco, et al.. (2020). Immunogenicity and Immune Silence in Human Cancer. Frontiers in Immunology. 11. 69–69. 21 indexed citations
4.
Carrer, Alessandro, Sophie Trefely, Steven Zhao, et al.. (2019). Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis. Cancer Discovery. 9(3). 416–435. 227 indexed citations
5.
Zou, Yongkang, Andrea Watters, Nan Cheng, et al.. (2019). Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis. Cancer Discovery. 9(12). 1720–1735. 117 indexed citations
6.
Barnoud, Thibaut, Joshua L.D. Parris, & Maureen E. Murphy. (2019). Common genetic variants in the TP53 pathway and their impact on cancer. Journal of Molecular Cell Biology. 11(7). 578–585. 45 indexed citations
7.
Yarmarkovich, Mark, Alvin Farrel, Moreno Di Marco, et al.. (2019). Immunogenicity and Immune Silence in Human Cancer. SSRN Electronic Journal. 1 indexed citations
8.
Barnoud, Thibaut, Joshua L.D. Parris, & Maureen E. Murphy. (2019). Tumor cells containing the African-Centric S47 variant ofTP53show increased Warburg metabolism. Oncotarget. 10(11). 1217–1223. 10 indexed citations
9.
Carrer, Alessandro, Joshua L.D. Parris, Sophie Trefely, et al.. (2017). Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels. Journal of Biological Chemistry. 292(8). 3312–3322. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026